Industries
Life Sciences
40+ years representing leading global life sciences & healthcare companies
Practices
Band 1
for US Nationwide, California and Massachusetts Life Sciences in 2022 — Chambers
Tier 1
for Healthcare: Life Sciences in 2021 — Legal 500 US
#1
consistent rank for global biotech & pharma licensing — BioPharm Insight
#1
in issuer-side life sciences IPOs since 2000
#1
for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook
Top 4
law firm for US biotech & pharma M&A volume since 2016 (Mergermarket + Pitchbook)
40+
Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies
"Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences
Defended more life sciences companies in shareholder litigation filed over the past ten years than any other firm
Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court
Complete wins in commercially significant drug ownership and licensing disputes
Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies
Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers
100+
Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies
5
Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers within our team
#4
Most Innovative Law Firm ranked by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients
Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking
Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors
As connectors to the ecosystem, we counsel clients on how to launch innovative products and services
Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience
Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers
Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications
#1
Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing
90+
person life sciences patent team across the US and UK (90% hold PhDs)
1,000+
IP due diligence reviews in life sciences deals/transactions
31,000
Patents currently under our management worldwide
1
The largest life sciences patent practice in the US
One of the most active IP litigation practices in the US with 500+ cases in the last 5 years
Complete wins in commercially significant drug ownership and licensing disputes
Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies
Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names
"Patent Strategy and Management Firm of the Year" Honoree – LMG Life Sciences (2018)
Cooley Rx
A virtual series focused on the life sciences and healthcare sectors
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
